Combined Chloroquine/Fansidar®-Resistant Falciparum Malaria Appears in East Africa

Urs Hess Kilimanjaro Christian Medical Centre, Tanzania Consultant Hospital, Moshi, Tanzania, East Africa

Search for other papers by Urs Hess in
Current site
Google Scholar
PubMed Close
,
Peter Maarten Timmermans Kilimanjaro Christian Medical Centre, Tanzania Consultant Hospital, Moshi, Tanzania, East Africa

Search for other papers by Peter Maarten Timmermans in
Current site
Google Scholar
PubMed Close
, and
Michael Jones Kilimanjaro Christian Medical Centre, Tanzania Consultant Hospital, Moshi, Tanzania, East Africa

Search for other papers by Michael Jones in
Current site
Google Scholar
PubMed Close
DOI:
https://doi.org/10.4269/ajtmh.1983.32.217
Volume/Issue:
Volume 32: Issue 2
Page(s):
217–220
Restricted access
Get Permissions

The first two cases from East Africa of RII chloroquine- and Fansidar®-resistant falciparum malaria are described. The first case occurred in a non-immune Swedish expatriate 2 weeks after arrival in Tanzania, and the second in a semi-immune Tanzanian soldier. Fansidar has not yet been marketed in Tanzania. The significance and etiology of the occurrence of combined chloroquine/Fansidar resistance in East Africa are discussed.

Author Notes

Present address: % Internal Department, Elisabeth's Gasthuis, Boerhaavelaan 22, 2035 RC Haarlem, The Netherlands.

Copyright:
Copyright © 1983 by The American Society of Tropical Medicine and Hygiene 1983
Accepted:
30 Jun 1982
|
Published Online:
Mar 1983
Cover The American Journal of Tropical Medicine and Hygiene
The American Journal of Tropical Medicine and Hygiene
Print ISSN:
0002-9637
Past two years Past Year Past 30 Days
Abstract Views 263 60 8
Full Text Views 12 0 0
PDF Downloads 3 0 0
 
Membership Banner
 
 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save